Status:
COMPLETED
Probiotic Modulation of Oral Microbiota
Lead Sponsor:
Prof. Jacques SCHRENZEL
Conditions:
Microbial Colonization
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Targeting human microbiota, in particular those of the gastrointestinal tract, by means of prebiotics, probiotics, symbiotics or antibiotics has gained interest for its potential in the management of ...
Detailed Description
OBJECTIVES This is a monocentric, prospective, cross-over, randomized, double-blinded study in which all participants will receive placebo and active probiotic treatment, 15 of which will first be tr...
Eligibility Criteria
Inclusion
- Informed Consent as documented by signature
- Good oral and general health
Exclusion
- Women who are pregnant or breast feeding
- Intention to become pregnant during the course of the study
- Systemic disease
- Previous enrolment into the current study
- Clinically diagnosed severe oral lesions
- Use of antibiotics and topical oral probiotics within the 3 months preceding the study or during the study
- Dental treatments and use of oral disinfectants within 30 days preceding the study or during the study
Key Trial Info
Start Date :
November 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 24 2022
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT04891523
Start Date
November 1 2021
End Date
October 24 2022
Last Update
May 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Geneva University Hospitals (HUG)
Geneva, Switzerland, 1211